Skip to main content
AAWH
OTC Life Sciences

Ascend Wellness Simplifies Capital Structure, Reapproves Stock Incentive Plan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.56
Mkt Cap
$113.192M
52W Low
$0.26
52W High
$1.2
52W Position info
115% above low
Off High info
53% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AAWH has more than doubled off its 52-week low of $0.26.

Summary

Ascend Wellness Holdings simplified its capital structure by converting all Class B common stock to Class A and reapproved its stock incentive plan at the annual meeting.


Key Events · Corporate Governance and Compliance · AAWH

  • Capital Structure Simplified

    All 65,000 outstanding shares of Class B common stock automatically converted into Class A common stock. Subsequently, the company filed a Certificate of Retirement to eliminate these Class B shares, reducing the total authorized common stock by 65,000 to 750,035,000 and authorized Class B stock to 35,000.

  • Stock Incentive Plan Reapproved

    Stockholders reapproved the company's stock incentive plan, including unallocated stock option entitlements, providing the company with continued flexibility for equity-based compensation.

  • Annual Meeting Results

    At the 2026 Annual Meeting, stockholders elected six directors to the Board and ratified the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2026.


Analysis · AAWH · Life Sciences

This filing details significant corporate governance actions. The conversion of all Class B common stock to Class A and the subsequent retirement of authorized Class B shares simplify the company's capital structure, enhancing transparency and potentially improving investor clarity. Additionally, the reapproval of the stock incentive plan is crucial for the company's ability to attract and retain talent, providing necessary flexibility for future equity compensation, which is particularly important given the company's recent financial downturn and stockholders' deficit.

At the time of this filing, AAWH was trading at $0.56 on OTC in the Life Sciences sector, with a market capitalization of approximately $113.2M. The 52-week trading range was $0.26 to $1.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AAWH - Latest Insights

AAWH
Jul 09, 2026, 5:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.410
Real-time Price: $0.40626 info
Change: -$0.00374 (-0.91%) info
Market Cap: $82.485M info
AAWH
Jun 25, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4475
Real-time Price: $0.40626 info
Change: -$0.04124 (-9%) info
Market Cap: $82.485M info
AAWH
Jun 25, 2026, 4:42 PM EDT
Filing Type: PREM14A
Importance Score:
7
Price at Filing: $0.4475
Real-time Price: $0.40626 info
Change: -$0.04124 (-9%) info
Market Cap: $82.485M info
AAWH
May 13, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5699
Real-time Price: $0.40626 info
Change: -$0.16364 (-29%) info
Market Cap: $82.485M info
AAWH
May 13, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5699
Real-time Price: $0.40626 info
Change: -$0.16364 (-29%) info
Market Cap: $82.485M info